Sen. Rand Paul (R-Ky.) announced Tuesday that he has subpoenaed Dr. Anthony Fauci, the former director of the National Institute of Allergy and Infectious Diseases, to testify before the Senate Homeland Security and Governmental Affairs Committee. The action escalates a years-long dispute over the origins of COVID-19 and U.S.-funded research. Paul stated that Fauci had initially agreed to testify voluntarily but later declined, necessitating the subpoena.

Allegations of Misconduct

Paul accused Fauci of misleading Congress about gain-of-function research, which involves intentionally altering viruses to study transmissibility. The Senator claimed that newly surfaced evidence strengthens his case that Fauci knowingly misled lawmakers regarding funding tied to the Wuhan Institute of Virology. Paul further alleged that the former NIH official attempted to shape early scientific narratives surrounding the virus's origin.

Broader Political Context

The renewed scrutiny comes as the debate over the lab-leak theory has intensified in Washington. In November, FDA Commissioner Marty Makary accused Fauci of suppressing early scrutiny of a possible lab-related origin of COVID-19. The controversy has also expanded to include questions about the role of the U.S. Agency for International Development (USAID) and its PREDICT program.

Key Figures and Statements

Fauci has repeatedly denied allegations that he misled Congress or helped cover up the virus's origins, previously calling similar claims "preposterous." Paul also questioned the scope of former President Joe Biden’s preemptive pardon for Fauci, suggesting its legal reach may face scrutiny.

President Donald Trump is scheduled to sign the 21st Century ROAD to Housing Act on Capitol Hill on Wednesday, marking the most significant federal housing legislation in over 30 years. The bipartisan bill aims to address the nation's severe housing shortage by increasing supply, reducing costs, and limiting the ability of large institutional investors to purchase single-family homes. This move comes as the median U.S. home price has risen 77% since 2011, reaching approximately $403,000, and buyers now spend about 42% of their income on housing.

Press Secretary Karoline Leavitt announced the signing on X, noting that the Senate passed the bill with an 85-5 vote. The legislation includes more than 45 provisions designed to improve affordability, including an Innovation Fund for communities that expand housing stock and targeted support for rural and manufactured housing. The bill also cuts regulatory red tape, which a study by the National Association of Home Builders found adds an average of $131,734 to the cost of a new single-family home, accounting for 26.4% of the final sale price.

Housing Supply and Cost Pressures

The U.S. housing market is currently grappling with a shortage of about 1.2 million units. Recent data indicates a sharp slowdown in construction activity, with housing starts falling 15.4% month over month in May to an annualized rate of 1.18 million units, the lowest level since May 2020. Multifamily housing starts saw an even steeper decline, dropping 40.2% to 284,000 units.

Impact on Investors and Affordability

While the bill introduces structural demand-side headwinds for real estate investment trusts and single-family rental operators, experts caution that its effectiveness may be limited. Redfin Chief Economist Daryl Fairweather warned that institutional investors could restructure holdings through smaller entities to sidestep ownership caps, potentially limiting real-world supply relief. The legislation arrives as homeownership rates among adults under 35 remain near their lowest levels in years, despite the median home price more than tripling since 1990.